2020
DOI: 10.1186/s13046-020-01548-4
|View full text |Cite
|
Sign up to set email alerts
|

Mesenchymal stromal cells mediated delivery of photoactive nanoparticles inhibits osteosarcoma growth in vitro and in a murine in vivo ectopic model

Abstract: Background: Osteosarcoma (OS) is an aggressive malignant neoplasm that still suffers from poor prognosis in the case of distal metastases or occurrence of multi-drug resistance. It is therefore crucial to find novel therapeutic options able to go beyond these limitations and improve patients' survival. The objective of this study is to exploit the intrinsic properties of mesenchymal stromal cells (MSCs) to migrate and infiltrate the tumor stroma to specifically deliver therapeutic agents directly to cancer cel… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
28
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
9
1

Relationship

2
8

Authors

Journals

citations
Cited by 37 publications
(29 citation statements)
references
References 70 publications
0
28
0
Order By: Relevance
“…The tumor-specific targeting components on the surface of stem cells make them a potent source of cell membranes for coating NPs designed to functionalize cell membranes. 48 , 49 To evaluate the ability of PDA-SN38@SCM NPs in targeting cancer cells in vitro, free SN38, PDA-SN38 NPs, or PDA-SN38@SCM NPs were incubated with MG63 cells for 4 h. CLSM and flow cytometry were used to analyze drug release in cancer cells by measuring the difference between the SN38 content in such cells. Compared with free SN38, MG63 cells treated with PDA-SN38@SCM NPs demonstrated higher fluorescence intensity upon stimulation with the same-intensity laser ( Figure 6A ).…”
Section: Resultsmentioning
confidence: 99%
“…The tumor-specific targeting components on the surface of stem cells make them a potent source of cell membranes for coating NPs designed to functionalize cell membranes. 48 , 49 To evaluate the ability of PDA-SN38@SCM NPs in targeting cancer cells in vitro, free SN38, PDA-SN38 NPs, or PDA-SN38@SCM NPs were incubated with MG63 cells for 4 h. CLSM and flow cytometry were used to analyze drug release in cancer cells by measuring the difference between the SN38 content in such cells. Compared with free SN38, MG63 cells treated with PDA-SN38@SCM NPs demonstrated higher fluorescence intensity upon stimulation with the same-intensity laser ( Figure 6A ).…”
Section: Resultsmentioning
confidence: 99%
“…Tumor recurrence, distant metastasis and chemoresistance are three important factors contributing to treatment failure and poor prognosis in OS (7,19). It has already been shown that CXCR4 plays a crucial role in OS survival and metastasis, and targeting CXCR4 is an effective strategy for OS (10)(11)(12).…”
Section: Discussionmentioning
confidence: 99%
“…Contrastingly, in PTT, the photosensitizer enters an excited state after NIR light radiation and generates various ROS from molecular oxygen. This NIR light‑induced release of ROS in PDT can kill cancer cells and damage the cancer vasculature, depriving the cancer of oxygen and nutrients 12 , 37 .…”
Section: Discussionmentioning
confidence: 99%